Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Critical Care

Figure 1

From: Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study

Figure 1

Admission levels of MR-proADM. (a) MR-proADM in patients with sepsis versus healthy control individuals. (b) MR-proADM in patients without infection (for example SIRS), and in patients with sepsis, severe sepsis and septic shock. (c) MR-proADM grouped according to PCT values. Lines denote median values, boxes represent 25–75th percentiles and whiskers indicate the range. The numbers of samples are indicated in parentheses. MR-proADM, mid-regional pro-adrenomedullin; PCT, procalcitonin; SIRS, systemic inflammatory response syndrome.

Back to article page